Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients
Top Cited Papers
- 1 August 2015
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 149 (2), 379-388
- https://doi.org/10.1053/j.gastro.2015.04.014
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Bariatric Surgery versus Intensive Medical Therapy in Obese Patients with DiabetesNew England Journal of Medicine, 2012
- Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesityNature, 2012
- A Two-Year Randomized Trial of Obesity Treatment in Primary Care PracticeNew England Journal of Medicine, 2011
- Risk of Bladder Cancer Among Diabetic Patients Treated With PioglitazoneDiabetes Care, 2011
- Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meaningsHepatology, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trialHepatology, 2008
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Design and validation of a histological scoring system for nonalcoholic fatty liver diseaseHepatology, 2005
- An algorithm for the grading of activity in chronic hepatitis CHepatology, 1996